2 Stocks Down by 25% or More This Year to Buy and Hold
Equity markets have had a rough go of it this year due to President Trump's macroeconomic policies. Though it can be challenging to navigate this environment, one way to make the best of it is to look for terrific stocks to invest in while they are down. Doing so could lead to outsized returns for patient, long-term investors.To that end, let's consider two stocks that have declined by at least 25% this year and look attractive: Viking Therapeutics (NASDAQ: VKTX) and PayPal (NASDAQ: PYPL).Drugmakers without a single therapy on the market tend to be somewhat risky, but investing in these companies early enough can lead to life-changing returns. Viking Therapeutics, a clinical-stage biotech, looks like one of the more attractive ones right now.Continue reading

Equity markets have had a rough go of it this year due to President Trump's macroeconomic policies. Though it can be challenging to navigate this environment, one way to make the best of it is to look for terrific stocks to invest in while they are down. Doing so could lead to outsized returns for patient, long-term investors.
To that end, let's consider two stocks that have declined by at least 25% this year and look attractive: Viking Therapeutics (NASDAQ: VKTX) and PayPal (NASDAQ: PYPL).
Drugmakers without a single therapy on the market tend to be somewhat risky, but investing in these companies early enough can lead to life-changing returns. Viking Therapeutics, a clinical-stage biotech, looks like one of the more attractive ones right now.